Skip to content
Login Register

#immune response

50 public questions tagged with this topic.

Vaccine

mRNA vaccines work by:

Messenger RNA vaccines represent nucleic acid platform delivering synthetic mRNA encoding pathogen antigen directly to host cytoplasm where host ribosomal machinery translates it transiently. Manufacturing involves in vitro transcription using T7 RNA polymerase from linearized plasmid DNA template encoding spike protein, incorporation of modified nucleoside N1 methylpseudouridine replacing uridine reducing TLR7 mediated inflammation and increasing translation half-life, addition of 5' cap 7-methylguanosine via vaccinia capping enzyme and 2'O-methylation, and 3' polyadenine tail 100 nt for stab

Ref: Pardi et al. Nat Rev Drug Discov 2018 mRNA mechanism; Polack NEJM mRNA; CDC mRNA work.

View Details
Immunological Applications

Subunit vaccines contain:

Whole pathogen vaccines contain complex mixture of antigens including immunodominant protective components but also many irrelevant proteins plus reactogenic factors such as lipid A endotoxin activating TLR4 causing fever, pertussis toxin ADP-ribosylating Gi, increasing reactogenicity and rare adverse events. Subunit vaccine strategy improves safety by purifying protective antigens through biochemical fractionation, recombinant expression, or synthetic peptide synthesis excluding toxic moieties. Hepatitis B vaccine exemplifies recombinant subunit: hepatitis B small surface antigen HBsAg gene c

Ref: NCERT Class XII Biology subunit purified antigen VLP HBsAg; Pulendran Nat Immunol 2011 alum NLRP3 adjuvant acellular pertussis.

View Details
Gene Therapy

Which viral vector shows very low immune response?

Recombinant AAV produced by triple transfection HEK293 cells with plasmids encoding rep/cap removed from vector, adenoviral helper functions E2A E4 VA RNA, and vector genome flanked by ITRs yields particles depleted viral coding sequences that normally generate PAMPs triggering innate and adaptive immunity. Capsid proteins VP1 VP2 VP3 ratio 1:1:10 from serotypes AAV2 AAV5 AAV9 exhibit low TLR2 mediated NF-kB activation and minimal TLR9 stimulation due to CpG depletion via codon optimization resulting reduced type I interferons, TNF-alpha, IL-12. Consequently transduced hepatocytes, muscle fibe

Ref: PMC AAV Low Immunogenicity Review PMCID 10142300; UQ Biomedical Sciences Vector Immunogenicity Comparison; Nature Med AAV Clinical Safety.

View Details
Cell Organelles

Which lysosomal membrane protein is required for fusion with phagosomes?

Phagosome maturation in macrophages and neutrophils converts a nascent bacteria-containing vacuole into a microbicidal phagolysosome through sequential interactions with early endosomes, late endosomes and terminal lysosomes. Acquisition of lysosomal membrane proteins marks progression, with lysosome-associated membrane proteins 1 and 2, LAMP1 and LAMP2, being the most abundant heavily glycosylated proteins delivered to maturing phagosomes, protecting membrane from hydrolases. Studies using LAMP-1 and LAMP-2 knockout mice and combined siRNA show single loss causes mild delay while double defic

Ref: Huynh et al., EMBO Journal 2007: LAMP Proteins Are Required for Fusion of Lysosomes with Phagosomes.

View Details